JPRN-UMIN000033911已完成未知
Analysis of allogenic stem cell transplantation for primary immunodeficiency using TRUMP data - Analysis of allo-HCT for PIDs in Japan
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 800
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •The patients whose TRUMP data are insufficient for analysis.
研究者
相似试验
进行中（未招募）
1 期
Allogeneic Stem Cell Transplantation after Reduced Intensity Conditioning for High-risk Relapsed or Refractory CChronic lymphocytic leukemiaMedDRA version: 14.1Level: LLTClassification code 10008978Term: Chronic lymphocytic leukemia refractorySystem Organ Class: 100000004864MedDRA version: 14.1Level: LLTClassification code 10008977Term: Chronic lymphocytic leukemia recurrentSystem Organ Class: 100000004864EUCTR2007-005487-28-NLHOVON Foundation50
已完成
2 期
Allogeneic Stem Cell Transplantation after Reduced Intensity Conditioning for High-risk Relapsed or Refractory CB-CLL10024324NL-OMON38321HOVO40
招募中
1 期
Phase I/II clinical trial to assess the safety and biological efficacy of treatment with virus-specific, cytotoxic T-lymphocytes from partially matched third-party unrelated donors, in stem cell transplant patients with viral reactivation unresponsive to standard therapy (R3ACT trial)ACTRN12613000603718Western Sydney Local Health Districit30
已完成
1 期
Stem Cell Transplant for Patients With Blood Malignancy Using Donors and Less Toxic Chemotherapy With CAMPATH 1HMyelodysplastic DisordersPlasma Cell DyscrasiaLymphoproliferative DisordersMultiple MyelomaLeukemiaNCT00048412Baylor College of Medicine40
进行中（未招募）
1 期
Allogeneic stem cell transplantation vs. conventional therapy as salvage therapy for relapsed / progressed patients with multiple myeloma after first-line therapyMedDRA version: 21.0Level: LLTClassification code 10028228Term: Multiple myelomaSystem Organ Class: 100000004864Multiple myelomaEUCTR2021-001005-67-DEniversity Medical Center Hamburg-Eppendorf482